KIT and small cell lung carcinoma: In this study, we use tyrphostins AG 1024 (IGF-1R inhibitor) and AG 1296 (PDGFR and c-kit inhibitor) to inhibit PTK activity in H 209 SCLC cells which present no PDGFR receptors.